134 related articles for article (PubMed ID: 601079)
1. Tay-Sachs heterozygote screening: specificity and sensitivity.
Scriver CR; Gold RJ
Prog Clin Biol Res; 1977; 18():239-43. PubMed ID: 601079
[TBL] [Abstract][Full Text] [Related]
2. Tay-Sachs disease heterozygote detection: a quality control study.
Kaback MM; Shapiro LJ; Hirsch P; Roy C
Prog Clin Biol Res; 1977; 18():267-79. PubMed ID: 601080
[No Abstract] [Full Text] [Related]
3. Automated thermal fractionation of serum hexosaminidase: effects of alteration in reaction variables and implications for Tay-Sachs disease heterozygote screening.
Kaback MM; Bailin G; Hirsch P; Roy C
Prog Clin Biol Res; 1977; 18():197-212. PubMed ID: 23554
[No Abstract] [Full Text] [Related]
4. Approaches to the control and prevention of Tay-Sachs disease.
Kaback MM; Zeiger RS; Reynolds LW; Sonneborn M
Prog Med Genet; 1974; 10():103-34. PubMed ID: 4620174
[TBL] [Abstract][Full Text] [Related]
5. Tay-Sachs disease: a pilot screening program for the detection of the heterozygote in the Charleston Jewish community.
Rogers JF; Hogan EL; Jorgenson RJ
South Med J; 1976 Nov; 69(11):1453-5. PubMed ID: 1019641
[TBL] [Abstract][Full Text] [Related]
6. Laboratory methods and quality control in the Toronto Tay-Sachs program.
Lowden JA; Skomorowski MA; Howard F
Prog Clin Biol Res; 1977; 18():221-6. PubMed ID: 601078
[No Abstract] [Full Text] [Related]
7. A fully automated method for identification of Tay-Sachs disease carriers by tear beta-hexosaminidase assay.
Desnick RJ; Truex JH; Goldberg JD
Prog Clin Biol Res; 1977; 18():245-65. PubMed ID: 23556
[No Abstract] [Full Text] [Related]
8. Carrier screening techniques for Tay-Sachs and other lysosomal storage diseases.
Kolodny EH
Prog Clin Biol Res; 1977; 18():213-9. PubMed ID: 601077
[No Abstract] [Full Text] [Related]
9. Screening for carriers of Tay-Sachs disease: A community project.
Lowden JA; Zuker S; Wilensky AJ; Skomorowski MA
Can Med Assoc J; 1974 Aug; 111(3):229-33. PubMed ID: 4854206
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff's disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population.
Andermann E; Scriver CR; Wolfe LS; Dansky L; Andermann F
Prog Clin Biol Res; 1977; 18():161-88. PubMed ID: 601075
[No Abstract] [Full Text] [Related]
11. Tay-Sachs screening and prevention: the Canadian experience.
Lowden JA; Davidson J
Prog Clin Biol Res; 1977; 18():37-46. PubMed ID: 601088
[No Abstract] [Full Text] [Related]
12. Computer assisted small-scale Tay-Sachs carrier screening.
Toney JH; Quirk JM
J Appl Biochem; 1983; 5(1-2):25-30. PubMed ID: 6236193
[TBL] [Abstract][Full Text] [Related]
13. Human hexosaminidase isozymes: chromatographic separation as an aid to heterozygote identification.
Nakagawa S; Kumin S; Nitowsky HM
Clin Chim Acta; 1977 Mar; 75(2):181-91. PubMed ID: 851488
[TBL] [Abstract][Full Text] [Related]
14. Tay-Sachs disease--the use of tears for the detection of heterozygotes.
Carmody PJ; Rattazzi MC; Davidson RG
N Engl J Med; 1973 Nov; 289(20):1072-4. PubMed ID: 4742222
[No Abstract] [Full Text] [Related]
15. Perspectives on screening and prevention of Tay-Sachs disease in Israel.
Padeh B; Shacher S; Katznelson MB; Navon R; Goldman B
Prog Clin Biol Res; 1977; 18():47-53. PubMed ID: 601094
[No Abstract] [Full Text] [Related]
16. Tay-Sachs disease in a Moroccan Jewish family: a possible new mutation.
Bach G; Navon R; Zeigler M; Beyth Y; Porter B; Cohen MM
Isr J Med Sci; 1976 Dec; 12(12):1432-9. PubMed ID: 1017941
[TBL] [Abstract][Full Text] [Related]
17. Absence of hexosaminidase A and B in a normal adult.
Dreyfus JC; Poenaru L; Svennerholm L
N Engl J Med; 1975 Jan; 292(2):61-3. PubMed ID: 1109441
[TBL] [Abstract][Full Text] [Related]
18. Tay-Sachs disease: heterozygote screening and prenatal diagnosis--U.S. experience and world perspective.
Kaback MM; Nathan TJ; Greenwald S
Prog Clin Biol Res; 1977; 18():13-36. PubMed ID: 601074
[No Abstract] [Full Text] [Related]
19. Automated determination of serum hexosaminidase A by pH inactivation for detection of Tay-Sachs disease heterozygotes.
Saifer A; Perle G
Clin Chem; 1974 May; 20(5):538-43. PubMed ID: 4826945
[No Abstract] [Full Text] [Related]
20. Economic considerations in genetic screening programs for Tay-Sachs disease.
Tsukahara T; Kadota RL
Prog Clin Biol Res; 1977; 18():319-27. PubMed ID: 601083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
